A single presumptive deworming may not suffice to reduce the burden of intestinal parasitic infections during pregnancy in rural Amhara, Ethiopia
Kalkidan Yibeltal, Firehiwot Workneh, Nebiyou Fasil, Estifanos Baye, Yunhee Kang, Workagegnhu Tarekegn Kidane, Sitota Tsegaye, Yoseph Yemane Berhane, Bethlehem Haymanot, Ingrid E. Olson, Mulatu Melese Derebe, Rose L. Molina, Blair J. Wylie, Grace J. Chan, Parul Christian

TL;DR
A single deworming treatment during pregnancy may not be enough to prevent intestinal parasites in rural Ethiopia.
Contribution
The study shows that prior deworming may not effectively prevent parasitic infections in pregnant women.
Findings
31% of pregnant women had parasitic infections after prior deworming.
Common infections included Giardia lamblia and Entamoeba histolytica.
15% of women reported gastrointestinal symptoms despite deworming.
Abstract
This study aimed to assess the prevalence of intestinal parasitic infections among pregnant women in the third trimester who received prior presumptive deworming in 12 health centers in the Amhara region, Ethiopia. This sub-study was part of the parent Enhancing Nutrition and Antenatal Infection Treatment (ENAT) study; a randomized clinical effectiveness study conducted to determine the effectiveness of packages of antenatal interventions to enhance maternal nutrition and infection management on birth outcomes. Three hundred fifty women provided a stool sample in their 3rd trimester for screening using wet mount microscopy. All women had previously received 500 mg of presumptive mebendazole in the 2nd trimester. One in three women (109/350, 31.0%) were found to have a parasitic stool infection after prior deworming and 15% of women reported gastrointestinal symptoms. The most common…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
- —http://dx.doi.org/10.13039/100000865Bill and Melinda Gates Foundation
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsParasites and Host Interactions · Child Nutrition and Water Access · Global Maternal and Child Health
Introduction
Infections during pregnancy including intestinal parasitic infections (IPIs) may cause anemia and nutrient malabsorption and thereby contribute to poor pregnancy weight gain, fetal growth restriction, and adverse pregnancy outcomes like low birth weight and preterm birth [1–3]. Systematic reviews of studies in Ethiopia report an overall prevalence of intestinal parasitic infections among pregnant women of 29-31.8% [4, 5]. The major categories of intestinal parasites during pregnancy include soil-transmitted helminths and protozoa [5, 6]. In settings with a high geo-helminthic burden like Ethiopia, the World Health Organization recommends prophylactic deworming in either the second or third trimesters of pregnancy, to reduce the burden of hookworm and Trichuris trichiura infection [7–9]. However, there are no recommendations for protozoal intestinal infection prophylaxis.
In this sub-study, we aimed to assess the prevalence, patterns for intestinal parasitic infections among pregnant women in rural Amhara Ethiopia. Current Ethiopian antenatal care guidelines recommend presumptive deworming in the second trimester with mebendazole. Most studies conducted previously in Ethiopia were cross-sectional studies which assessed the prevalence of intestinal parasitic infections (IPIs) or coverage of deworming at a single time point [7, 10–13]. For studies, examine the prevalence of IPIs after provision of presumptive deworming. In the current study, we examine the prevalence of IPI’s among women in the third trimester of pregnancy post-prophylactic deworming.
The findings of this study provide evidence on the literature gap to guide future strategies on the control IPIs in pregnancy.
Methods
This study is nested under the parent Enhancing Nutrition and Antenatal Infection Treatment (ENAT) study (ISRCTN15116516). ENAT study was 2 × 2 factorial pragmatic, open-label, randomized clinical effectiveness study conducted in rural health centers in the Amhara region, Northwest Ethiopia, to determine the effectiveness of packages of antenatal interventions to enhance maternal nutrition and infection management on birth outcomes. Further details about the ENAT study are published elsewhere [14]. ENAT participants who were randomized to the enhanced infection management package (EIMP) received routine presumptive deworming of a single dose of 500 mg mebendazole followed by wet-mount microscopy stool examination one month later with tailored treatment if they were positive. Treatment was guided per the National Ministry of Health treatment guidelines [15].
Stool samples were collected subsequently from a subset of 350 pregnant women consecutively enrolled in the EIMP arm presenting for antenatal care (ANC) in the 3rd trimester regardless of their symptoms and who had received a presumptive mebendazole (500 mg oral tablet) at least a month prior. Mothers were observed taking the mebendazole at the health center pharmacy. The stool samples were screened for intestinal parasites in the study health centers’ laboratory using the national standard of care, wet-mount microscopy [16, 17]. Wet mount microscopy has 37.1% sensitivity and 100% specificity in detecting intestinal parasites [18].
Result
Post mebendazole deworming, 31% (109 cases out of 350 screened) of women had a parasitic stool infection in 3rd trimester, where 6 of them had coinfections with more than one parasite (Table 1). Of the 335 mothers provided data on the presence of gastrointestinal (GI) symptoms in the past 7 days (severe abdominal pain, diarrhea, nausea, vomiting, and constipation) on the day of stool sample collection, where only 50 (14.9%) had any one or more symptoms while reported having at least one symptom whilethe remaining 285 (85.1%) were asymptomatic. Among women who had parasitic stool infections in the 3rd trimester, approximately 19.4% reported GI symptoms (20/103). The three most common intestinal parasites identified in the study population were the protozoa, Giardia lamblia (n = 43/109, 39%), Entamoeba histolytica (n = 40/109, 37%), followed by Hookworm (n = 23/109, 21.1%). The detailed parasitic profile is indicated in Table 1.
Table 1. Prevalence and types of intestinal parasitic infections among pregnant women in 3rd trimester post-presumptive deworming (n = 350), Amhara region, EthiopiaParasitesNumber (Percent)Stool examinations completed350 (100%)Pregnant women with identified stool parasite(s)109 (31.0%) Giardia lamblia (Trophozoite & cyst)43 (37.4%) Entamoeba histolytica (Trophozoite & cyst)40 (34.8%) Hookworm25 (21.7%) Ascaris lumbricoides3 (2.6%) Schistosoma mansoni1 (0.9%) Schistosoma haematobium1 (0.9%) Strongyloides stercoralis1 (0.9%)
The sociodemographic characteristics of the pregnant women in the study are shown in Table 2. The median maternal age was 25 (IQR 22, 30). The majority of mothers worked in agricultural labor and had no formal education. Most women reported having access to a public tap and dug well sources (n = 86.5%) for drinking water and improved toilet facilities (n = 230, 66.3%).
Table 2. Sociodemographic characteristics and correlations with intestinal parasitic infection (n = 350), Amhara region, EthiopiaVariablesVariable categoriesIPIs detectedIPIs not detectedSig.Age (years)16–2028 (36.8%)48 (63.2%)0.6021–2530 (27.3%)80 (72.7%)26–3035 (32.4%)73 (67.6%)31–359 (25.0%)27 (75.0%)36–457 (35.0%)13 (65.0%)Marital status †Never married/ never lived together6 (46.2%)7 (53.8%)0.24Married/ living together103 (30.8%)232 (69.2%)Educational status ‡No formal education56 (37.3%)94 (62.7%)0.09Primary or lower31 (29.3%)75 (70.7%)Secondary or higher22 (24.2%)69 (75.8%)Occupation †Agriculture / daily laborer63 (36.2%)111 (63.8%)0.12Informal24 (24.5%)74 (75.5%)Waged occupation22 (28.9%)54 (71.1%)Family size ‡<=239 (29.8%)92 (70.2%)0.403 to 545 (29.8%)106 (70.2%)> 525 (38.5%)40 (61.5%)Agricultural land ownership ‡No33 (33.3%)66 (66.7%)0.63Yes76 (30.6%)172 (69.4%)Milk cows or bulls ownership ‡No41 (30.2%)95 (69.8%)0.68Yes68 (32.2%)143 (67.8%)Primary source of water for drinking ‡Unimproved15 (31.9%)32 (68.1%)0.94Improved**94 (31.3%)206 (68.7%)Toilet facility ‡Unimproved ^ϑ^38 (32.5%)79 (67.5%)0.76Improved ^ϑϑ^71 (30.9%)159 (69.1%) Unimproved water source - Water from spring, Surface water, rainwater as per the Ethiopia Demographic and Health Survey (EDHS) [19] ** Improved water source- Public tap and dug well [19]^ϑ^ Unimproved toilet facility- - No facility/ bush/ field [19]^ϑϑ^ Improved toilet facility- Pit latrine, Ventilated pit latrine, composite toilet [19]† Marital status and occupation available for n = 348‡ Educational status, family size, Primary source of water for drinking, Milk cows or bulls ownership, primary source of water for drinking, and toilet facility available for n = 347
Discussion
The prevalence of intestinal parasitic infections in late pregnancy is high in rural Amhara where one in three pregnant women harbored parasitic infections in late pregnancy despite prior administration of presumptive mebendazole deworming earlier in the pregnancy. Eventhough, most studies are conducted on the general burden of intestinal parasitic infection during pregnancy regardless of presumptive deworming, our study findings are comparable to the estimated pooled prevalence of IPIs among pregnant women in a systematic review and meta-analysis conducted in Ethiopia [4] and Felege Hiwot Referral Hospital [20]. The prevalence was less than studies conducted in Mecha district, Northwest Ethiopia, Lalo Kile district, Oromia, and Woreilu Health Center, Northeast Ethiopia [11, 21, 22].
Most of the parasites identified in this study population were protozoan infections (Giardia and Amoeba) which are not adequately covered by mebendazole [23]. Secondly, studies in similar settings have shown that the cure rates of hookworm with a single dose of albendazole/ mebendazole treatment were low [24–26]. Certain populations may have a degree of innate resistance to the medications in use. Thus, it is imperative to investigate whether the intestinal parasites in the study area have developed resistance to the widely used anthelmintic, and if alternate regimens should be considered first line. Drug resistance to mebendazole in human hookworms has been reported in Mali [27]. It is also important to study rates of reinfection and good to obtain a baseline stool examination data. Finally, the other factors contributing to to recurrence of IPIs related to poor sanitation and hygiene and low socioeconomic status should be studied.
Thus, this study provides valuable insight into the prevalence of parasitic infections among pregnant women in the current context in Amhara, with implications for altering the current treatment regimens and if supported with further studies to suggest the need for presumptive protozoal treatment. It is critical to understand the type and prevalence of intestinal parasitic infections in the specific setting to better tailor clinical management and recommendations since most anthelmintic and antiparasitic drugs such as metronidazole, praziquantel, pyrantel, and mebendazole/ albendazole are safe to be administered during pregnancy, especially after the first trimester [16]. Identifying the right dose, regime, and type of drug is needed to effectively treat IP during pregnancy and thereby reduce adverse pregnancy outcomes. Thus, future research is needed to inform optimal prophylaxis and treatment regimens in pregnancy.
Limitations
Stool examination was performed using direct wet mount microscopy, the standard of care at the health center level in Ethiopia [15, 16]. This method has lower sensitivity than other techniques such as the formol-ether concentration technique [18, 28]. However, if this method resulted in the under-detection of infections, then the prevalence of IP infections would be higher than we have reported in the current study. We did not have baseline/pre-treatment stool samples for comparison, and we could not determine the effectiveness of mebendazole or whether individuals were re-infected within a month of testing. The sample size was not adequately powered to look for association with important factors. However, we acknowledge that even though most of the study participants had access to improved water sources, the storage and handling of the water could also serve as one source of infection which we haven’t assessed in our study [29].
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Soil-transmitted helminth infections. https://www.who.int/news-room/fact-sheets/detail/soil-transmitted-helminth-infections (accessed 17 June 2024).
- 2STG-General Hospital. EFDA. 2023. http://www.efda.gov.et/publication/stg-general-hospital/ (accessed 3 July 2024).
- 3STG, -Health Center. EFDA. 2024. http://www.efda.gov.et/publication/stg-health-center/ (accessed 30 August 2024).
- 4Ejigu K, Hailu T, Alemu M. Efficacy of Mebendazole and praziquantel against Soil-Transmitted helminths and Schistosoma mansoni infections among schoolchildren in Northwest Ethiopia. 10.1155/2021/668241810.1155/2021/6682418 PMC 830239234327236 · doi ↗ · pubmed ↗
- 5Clercq DD, Sacko M, Behnke J et al. Failure of Mebendazole in treatment of human hookworm infections in the Southern region of Mali. Published online first: 1 July 1997. 10.4269/ajtmh.1997.57.2510.4269/ajtmh.1997.57.259242313 · doi ↗ · pubmed ↗
